Forte Biosciences (FBRX) IV bid into data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts FBRX Hot Sheet
Join SI Premium – FREE
Forte Biosciences (NASDAQ: FBRX) August call option implied volatility is at 230, September is at 275; compared to its 52-week range of 87 to 265 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IREN Limited (IREN) call put ratio 2.6 calls to 1 put as share price up 7.7%
- Eli Lilly & Co. (LLY) call put ratio 1 call to 1.8 puts into quarter results
- GE Vernova (GEV) call put ratio 1.3 calls to 1 put into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
